Given its formerly reported importance for diagnosing, monitoring and evaluating the prognosis of pulmonary fibrosis in ILDs, the results achieved hitherto cannot exclude a possible, adjunctive role of KL-6 in estimating the fibrotic evolution of COVID-19 interstitial pneumonia in patients who recovered from acute disease [12,13,20]. Here, MUC1 is linked to COVID-19.